Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moukil, M. A.
Right arrow Articles by Van Schaftingen, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moukil, M. A.
Right arrow Articles by Van Schaftingen, E.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 2 195-201, Copyright © 2000 by American Diabetes Association

ARTICLES

Study of the regulatory properties of glucokinase by site-directed mutagenesis: conversion of glucokinase to an enzyme with high affinity for glucose

MA Moukil, M Veiga-da-Cunha and E Van Schaftingen
Laboratoire de Chimie Physiologique, Christian de Duve Institute of Cellular Pathology and Universite Catholique de Louvain, Brussels, Belgium.

To identify the amino acids involved in the specific regulatory properties of glucokinase, and particularly its low affinity for glucose, mutants of the human islet enzyme have been prepared, in which glucokinase-specific residues have been replaced. Two mutations increased the affinity for glucose by twofold (K296M) and sixfold (Y214A), the latter also decreasing the Hill coefficient from 1.75 to 1.2 with minimal change in the affinity for ATP. Combining these two mutations with N166R resulted in a 50-fold decrease in the half-saturating substrate concentration (S0.5) value, which became then comparable to the Km of hexokinase II. The location of N166, Y214, and K296 in the three-dimensional structure of glucokinase suggests that these mutations act by favoring closure of the catalytic cleft. As a rule, mutations changed the affinity for glucose and for the competitive inhibitor mannoheptulose (MH) in parallel, whereas they barely affected the affinity for N-acetylglucosamine (NAG). These and other results suggest that NAG and MH bind to the same site but to different conformations of glucokinase. A small reduction in the affinity for the regulatory protein was observed with mutations of residues on the smaller domain and in the hinge region, confirming the bipartite nature of the binding site for the regulatory protein. The K296M mutant was found to have a threefold decreased affinity for palmitoyl CoA; this effect was additive to that previously observed for the E279Q mutant, indicating that the binding site for long-chain acyl CoAs is located on the upper face of the larger domain.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Am. Podiatr. Med. Assoc.Home page
M. A. Brenner, L. B. Harkless, R. W. Mendicino, and J. C. Page
Ciclopirox 8% Nail Lacquer Topical Solution for the Treatment of Onychomycosis in Patients with Diabetes: A Multicenter, Open-Label Study
J Am Podiatr Med Assoc, May 1, 2007; 97(3): 195 - 202.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. V. Heredia, T. J. Carlson, E. Garcia, and S. Sun
Biochemical Basis of Glucokinase Activation and the Regulation by Glucokinase Regulatory Protein in Naturally Occurring Mutations
J. Biol. Chem., December 29, 2006; 281(52): 40201 - 40207.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Zhang, C. Li, K. Chen, W. Zhu, X. Shen, and H. Jiang
Conformational transition pathway in the allosteric process of human glucokinase
PNAS, September 5, 2006; 103(36): 13368 - 13373.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Baltrusch, F. Francini, S. Lenzen, and M. Tiedge
Interaction of Glucokinase With the Liver Regulatory Protein Is Conferred by Leucine-Asparagine Motifs of the Enzyme
Diabetes, October 1, 2005; 54(10): 2829 - 2837.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
L. Pedelini, M. A. Garcia-Gimeno, A. Marina, J. M. Gomez-Zumaquero, P. Rodriguez-Bada, S. Lopez-Enriquez, F. C. Soriguer, A. L. Cuesta-Munoz, and P. Sanz
Structure--function analysis of the {alpha}5 and the {alpha}13 helices of human glucokinase: Description of two novel activating mutations
Protein Sci., August 1, 2005; 14(8): 2080 - 2086.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. L. Gloyn, S. Odili, D. Zelent, C. Buettger, H. A. J. Castleden, A. M. Steele, A. Stride, C. Shiota, M. A. Magnuson, R. Lorini, et al.
Insights into the Structure and Regulation of Glucokinase from a Novel Mutation (V62M), Which Causes Maturity-onset Diabetes of the Young
J. Biol. Chem., April 8, 2005; 280(14): 14105 - 14113.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. L. Cuesta-Munoz, H. Huopio, T. Otonkoski, J. M. Gomez-Zumaquero, K. Nanto-Salonen, J. Rahier, S. Lopez-Enriquez, M. A. Garcia-Gimeno, P. Sanz, F. C. Soriguer, et al.
Severe Persistent Hyperinsulinemic Hypoglycemia due to a De Novo Glucokinase Mutation
Diabetes, August 1, 2004; 53(8): 2164 - 2168.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. J. Brocklehurst, V. A. Payne, R. A. Davies, D. Carroll, H. L. Vertigan, H. J. Wightman, S. Aiston, I. D. Waddell, B. Leighton, M. P. Coghlan, et al.
Stimulation of Hepatocyte Glucose Metabolism by Novel Small Molecule Glucokinase Activators
Diabetes, March 1, 2004; 53(3): 535 - 541.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. L. Gloyn, K. Noordam, M. A.A.P. Willemsen, S. Ellard, W. W.K. Lam, I. W. Campbell, P. Midgley, C. Shiota, C. Buettger, M. A. Magnuson, et al.
Insights Into the Biochemical and Genetic Basis of Glucokinase Activation From Naturally Occurring Hypoglycemia Mutations
Diabetes, September 1, 2003; 52(9): 2433 - 2440.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. A. Dunn-Meynell, V. H. Routh, L. Kang, L. Gaspers, and B. E. Levin
Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons
Diabetes, July 1, 2002; 51(7): 2056 - 2065.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. B.T. Christesen, B. B. Jacobsen, S. Odili, C. Buettger, A. Cuesta-Munoz, T. Hansen, K. Brusgaard, O. Massa, M. A. Magnuson, C. Shiota, et al.
The Second Activating Glucokinase Mutation (A456V): Implications for Glucose Homeostasis and Diabetes Therapy
Diabetes, April 1, 2002; 51(4): 1240 - 1246.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Hawkins, I. Gabriely, R. Wozniak, C. Vilcu, H. Shamoon, and L. Rossetti
Fructose Improves the Ability of Hyperglycemia Per Se to Regulate Glucose Production in Type 2 Diabetes
Diabetes, March 1, 2002; 51(3): 606 - 614.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Veiga-da-Cunha and E. Van Schaftingen
Identification of Fructose 6-Phosphate- and Fructose 1-Phosphate-binding Residues in the Regulatory Protein of Glucokinase
J. Biol. Chem., March 1, 2002; 277(10): 8466 - 8473.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. A. Moukil and E. Van Schaftingen
Analysis of the Cooperativity of Human beta -Cell Glucokinase through the Stimulatory Effect of Glucose on Fructose Phosphorylation
J. Biol. Chem., February 2, 2001; 276(6): 3872 - 3878.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.